Rezolute Inc (RZLT) Company Profile & Statistics

Rezolute Inc
RZLT
(Nasdaq - US)
N/A
2.62
+0.06 (+2.34%)
in:usd•As of: May 17, 2024 15:59 UTC -4
Open
2.58
High
2.72
Low
2.58

About Rezolute Inc

CEO

Nevan Charles Elam

Headquarters

275 shoreline drive, suite 500

redwood city, ca 94065, united states

Auditor

Plante & Moran, PLLC

Employees

Share Holders

274

Website

www.rezolutebio.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Rezolute, Inc. is a biopharmaceutical company specializing in the development of drug therapies for metabolic and orphan diseases. The Company's products include AB101, RZ358, RZ402 and RZ602 which are in clinical stage. Rezolute, Inc., formerly known as AntriaBio, Inc., is based in LOUISVILLE, United States.

Rezolute Inc Statistics

Valuation Measures

Market Capitalization ²	105.14M
Enterprise Value	99.21M
Enterprise Value/EBITDA (ttm)	-1.54
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.45
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-60.90%
Return on Invested Capital (ttm)	-64.20%
Return on Assets (ttm)	-54.58%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-64.28M
Net Income Avi to Common (ttm)	-58.21M
Diluted EPS (ttm)	-1.14

Share Statistics

Beta (5Y Monthly)	1.29
52-Week Change	25.36%
S&P500 52-Week Change	26.33%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	40.14M
Dividend Yield	0.00%
Float ⁴	31.78M
% Held by Insiders	20.80%
% Held by Institutions	82.97%

Balance Sheet

Total Cash (mrq)	80.02M
Total Cash Per Share (mrq)	1.99
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	11.82%
Quick Ratio (mrq)	12.00%
Book Value Per Share (mrq)	1.77

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.76
Free Cash Flow (ytd)	-38.85M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Rezolute Inc

Trade With A Regulated Broker